GO
Loading...

Pharmaceuticals

More

  • NEW YORK/ BOSTON, Aug 20- A few months ago, an innovative partnership between Valeant Pharmaceuticals and billionaire investor William Ackman to buy Botox maker Allergan Inc looked like a blueprint for success.

  • FDA approves new drug for rare genetic disease Tuesday, 19 Aug 2014 | 6:00 PM ET

    Cerdelga is from Genzyme, the specialty drugmaker that introduced the first drug for Gaucher's disease 20 years ago. The oral treatment could serve as an alternative to Genzyme's best-selling drug Cerezyme, which is given intravenously. Genzyme says it will soon release pricing for its new drug.

  • Aug 19- Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street Journal said. Allergan and Salix declined to comment on the matter.

  • AstraZeneca says DOJ closes probe into drug trial Tuesday, 19 Aug 2014 | 12:39 PM ET

    WASHINGTON— British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action. The London- based drugmaker said in a statement Tuesday: " AstraZeneca has always had absolute confidence in the integrity of the PLATO trial."

  • Fighting obesity with Rxs     Monday, 18 Aug 2014 | 2:17 PM ET

    Zafgen CEO Tom Hughes discusses the company's dedication to tackle obesity, with CNBC's Meg Tirrell. Hughes says the new drug works to impact the way the body handles fat.

  • Next wave of diet drugs     Monday, 18 Aug 2014 | 1:16 PM ET

    Obesity has big potential for drug makers. CNBC's Meg Tirrell examines why physicians have been cautious to adopt new diet drugs.

  • Allergan names Hindman chief financial officer Monday, 18 Aug 2014 | 1:12 PM ET

    IRVINE, Calif.— Botox maker Allergan, which is fighting a hostile takeover bid from Valeant Pharmaceuticals, has named longtime executive Jim Hindman its new chief financial officer. Allergan Chairman and CEO David E.I. Pyott said in a statement from the company that Edwards told him back in February that he was thinking about stepping down later in the year.

  • Obesity treatment sales fall short     Monday, 18 Aug 2014 | 6:26 AM ET

    CNBC's Meg Tirrell provides insight to the definition of obesity by the CDC, and which drug companies are working on treatments in the space.

  • TOKYO, Aug 18- Japan's Nikkei ended flat on Monday in thin trade as geopolitical tensions dulled risk appetite, but Chugai Pharmaceutical jumped on a media report that Roche Holding AG's may be close to sealing a deal to take full ownership of the Japanese drugmaker. The Nikkei was flat at 15,322.60 in choppy trade.

  • WASHINGTON, August 18- Establishing a tax domicile abroad to avoid U.S. taxes is a hot strategy in corporate America, but many companies that have done such "inversion" deals have failed to produce above-average returns for investors, a Reuters analysis has found.

  • TOKYO, Aug 18- Japan's Nikkei was choppy on Monday morning as geopolitical tensions checked risk appetite, but Chugai Pharmaceutical jumped on a media report that Roche Holding AG's may be close to sealing a deal to gain full ownership of the Japanese drugmaker.

  • LOS ANGELES, Aug 17- Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies.

  • NORWICH, England, Aug 17- Pampering leafcutter ants with fragrant rose petals and fresh oranges may seem an unlikely way to rescue modern medicine, but scientists at a lab in eastern England think it's well worth trying.

  • Alabama high court upholds generic drug decision Friday, 15 Aug 2014 | 3:23 PM ET

    MONTGOMERY, Ala.— Brand-name drug makers can be held liable for warnings on a generic medication even if it was produced by another company, the Alabama Supreme Court ruled Friday, standing by an earlier decision that business leaders viewed as a defeat.

  • Is climate change key to the spread of Ebola? Friday, 15 Aug 2014 | 5:56 AM ET
    Women washing along the Niger River near Babila, Guinea.

    Ebola outbreaks may become more frequent because of climate change, scientists warn, as the deadly disease ravages West Africa.

  • BOSTON, Aug 14- Billionaire investor William Ackman, who often says he is flattered when others follow him into a stock he likes, was joined by several prominent hedge funds that made new bets on takeover target Allergan Inc during the second quarter.

  • Aug 14- Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock.

  • SAN FRANCISCO, Aug 14- A group of ex-gaming industry executives say they can use their design chops to solve a major health challenge: Sick patients neglecting to take their medication and costing employers and insurance providers billions of dollars.

  • Cohen must face insider trading case: Judge Thursday, 14 Aug 2014 | 4:18 PM ET
    Steve Cohen

    U.S. District Judge Victor Marrero in Manhattan allowed the entire case against Cohen and SAC to go forward, apart from some claims brought too late.

  • Aug 14- U.S. securities regulators are looking at the hostile takeover bid made by billionaire investor William Ackman and Valeant Pharmaceuticals for Botox maker Allergan Inc, a person familiar with the matter said on Thursday.